Cargando…

Exploring the Gut Microbiota and Cardiovascular Disease

Cardiovascular disease (CVD) has been classified as one of the leading causes of morbidity and mortality worldwide. CVD risk factors include smoking, hypertension, dyslipidaemia, obesity, inflammation and diabetes. The gut microbiota can influence human health through multiple interactions and commu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, Kiera, O’Donovan, Aoife N., Caplice, Noel M., Ross, R. Paul, Stanton, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401482/ https://www.ncbi.nlm.nih.gov/pubmed/34436434 http://dx.doi.org/10.3390/metabo11080493

Ejemplares similares

Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions
por: Ryan, Paul M., et al.
Publicado: (2017)

Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E(−/−) mice
por: Ryan, Paul M., et al.
Publicado: (2017)

Early Gut Microbiota Perturbations Following Intrapartum Antibiotic Prophylaxis to Prevent Group B Streptococcal Disease
por: Mazzola, Giuseppe, et al.
Publicado: (2016)

The Gut Microbiota Composition in Dichorionic Triplet Sets Suggests a Role for Host Genetic Factors
por: Murphy, Kiera, et al.
Publicado: (2015)

Long-term dietary intake from infancy to late adolescence is associated with gut microbiota composition in young adulthood
por: Oluwagbemigun, Kolade, et al.
Publicado: (2021)

Protocol for a prospective cohort study exploring the gut microbiota of infants with congenital heart disease undergoing cardiopulmonary bypass (the GuMiBear study)
por: Magner, Claire, et al.
Publicado: (2023)

The composition of the gut microbiota throughout life, with an emphasis on early life
por: Rodríguez, Juan Miguel, et al.
Publicado: (2015)

Role of Gut Microbiota in Early Infant Development
por: Wall, R, et al.
Publicado: (2009)

The Gut Microbiota of Marine Fish
por: Egerton, Sian, et al.
Publicado: (2018)

Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort
por: Hill, Cian J., et al.
Publicado: (2017)

Erratum to: Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort
por: Hill, Cian J., et al.
Publicado: (2017)

Metabolomic Workflow for the Accurate and High-Throughput Exploration of the Pathways of Tryptophan, Tyrosine, Phenylalanine, and Branched-Chain Amino Acids in Human Biofluids
por: Anesi, Andrea, et al.
Publicado: (2022)

Role of gut microbiota in cardiovascular diseases
por: Novakovic, Marko, et al.
Publicado: (2020)

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
por: Chen, Xiaofeng, et al.
Publicado: (2023)

Implication of Gut Microbiota in Cardiovascular Diseases
por: Zhou, Wenyi, et al.
Publicado: (2020)

Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases
por: Chen, Jingyuan, et al.
Publicado: (2018)

Endocrine organs of cardiovascular diseases: Gut microbiota
por: Jia, Qiujin, et al.
Publicado: (2019)

Gut microbiota and cardiovascular disease: opportunities and challenges
por: Kazemian, Negin, et al.
Publicado: (2020)

The Gut Microbiota in Cardiovascular Disease and Arterial Thrombosis
por: Lässiger-Herfurth, Anna, et al.
Publicado: (2019)

The role of the gut microbiota in health and cardiovascular diseases
por: Wang, Lu, et al.
Publicado: (2022)

The emerging role of gut microbiota in cardiovascular diseases
por: Kumar, Dilip, et al.
Publicado: (2021)

Diet-gut microbiota interactions on cardiovascular disease
por: Zhang, Xufei, et al.
Publicado: (2022)

Beneficial Microbes: The pharmacy in the gut
por: Linares, Daniel M., et al.
Publicado: (2015)

The Composition of Human Milk and Infant Faecal Microbiota Over the First Three Months of Life: A Pilot Study
por: Murphy, Kiera, et al.
Publicado: (2017)

Modulation of the gut microbiome with nisin
por: O’Reilly, Catherine, et al.
Publicado: (2023)

Gut microbiota derived metabolites in cardiovascular health and disease
por: Wang, Zeneng, et al.
Publicado: (2018)

Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
por: Brial, Francois, et al.
Publicado: (2018)

Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases
por: Oniszczuk, Anna, et al.
Publicado: (2021)

Honeybee Exposure to Veterinary Drugs: How Is the Gut Microbiota Affected?
por: Baffoni, Loredana, et al.
Publicado: (2021)

Priming for Life: Early Life Nutrition and the Microbiota-Gut-Brain Axis
por: Ratsika, Anna, et al.
Publicado: (2021)

Gut Microbiota and Cardiovascular Uremic Toxicities
por: Velasquez, Manuel T., et al.
Publicado: (2018)

The Sporobiota of the Human Gut
por: Egan, Muireann, et al.
Publicado: (2021)

Recent advances in modulation of cardiovascular diseases by the gut microbiota
por: Masenga, Sepiso K., et al.
Publicado: (2022)

Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis
por: Murphy, Kiera, et al.
Publicado: (2021)

Update on gut microbiota in cardiovascular diseases
por: Qian, Buyun, et al.
Publicado: (2022)

COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response
por: Ryan, Paul MacDaragh, et al.
Publicado: (2020)

Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
por: Leblond, Anne-Laure, et al.
Publicado: (2009)

The influence of gut microbiota in cardiovascular diseases—a brief review
por: Almeida, Cátia, et al.
Publicado: (2021)

The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases
por: Sanchez-Rodriguez, Estefania, et al.
Publicado: (2020)

Gut Microbiota and Sex Hormones: Crosstalking Players in Cardiometabolic and Cardiovascular Disease
por: Maffei, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7j31m1jqtm524qdp06cg2j4tdm